Lignocaine N-oxide
Lignocaine N-oxide (Lidocaine N-oxide) is a compound derived from the metabolism of lidocaine. Lidocaine can be metabolized to its N-oxide in rat liver microsomes.
Product Specifications
CAS Number
[2903-45-9]
Product Name Alternative
Lidocaine N-oxide
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/lignocaine-n-oxide.html
Concentration
10mM
Purity
99.92
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C[N+](CC)(CC)[O-])NC1=C(C)C=CC=C1C
Molecular Formula
C14H22N2O2
Molecular Weight
250.34
Precautions
H302, H315, H319, H335
References & Citations
[1]In-vitro metabolism of lignocaine to its N-oxide
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15305504 1 Vial
Lentiviral mouse Vps16 shRNA (UAS) - Lentiviral mouse Vps16 shRNA (UAS) (25)
Ask
View Details 
MBS6340465-01 0.1 mL
RASGRP1, ID (RASGRP1, RASGRP, RAS guanyl-releasing protein 1, Calcium and DAG-regulated guanine nucleotide exchange factor II, Ras guanyl-releasing protein) (MaxLight 405)
Ask
View Details MBS6340465-02 5x 0.1 mL
RASGRP1, ID (RASGRP1, RASGRP, RAS guanyl-releasing protein 1, Calcium and DAG-regulated guanine nucleotide exchange factor II, Ras guanyl-releasing protein) (MaxLight 405)
Ask
View Details 